They are mostly found in fish and marine organisms and provide several health benefits. Growing consumer awareness about the numerous health benefits of EPA and DHA has fueled their demand in dietary supplements, infant formula and other food and beverages.
The EPA and DHA market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2030. The market is driven by rising health consciousness, growing vegan population and increasing adoption of EPA and DHA in infant formula.
Key Takeaways
Key players: Key players operating in the Global EPA And DHA Market Size include Croda Inc, BASF SE, DSM, Epax Norway AS, Golden Omega, GC Rieber, Lonza, Orkla Health, and TASA Omega. These players are focusing on new product development and mergers & acquisitions to gain a competitive edge in the market.
Key opportunities: Rising demand for plant-based and vegetarian EPA and DHA options due to increasing vegan population presents significant opportunities for key players. Growth opportunities also exist in developing innovative delivery formats like gummies, chews and beverages to attract health-conscious consumers.
Global expansion: Leading companies are expanding their global footprint by investing in production facilities across regions. For instance, Golden Omega has production facilities in the US, Chile and Norway to meet the growing demand. DSM and BASF are also focusing on strategic acquisitions for global capacity expansion.
Market drivers: Growing consumer awareness about the role of EPA and DHA in supporting brain health and pregnancy outcomes is a major market driver. Rising adoption of EPA and DHA supplements during pregnancy due to changing lifestyles is bolstering market growth.
Market restraints: High production costs associated with EPA and DHA extraction limit profit margins. Dependence on wild fish stocks also makes the supply chain unsustainable. Strict regulatory norms regarding quality standards further constrain market potential.
Segment Analysis
The EPA and DHA market is dominated by the supplement sub-segment. This is because increasing health consciousness among consumers has led to rising demand for omega-3 fatty acid supplements. EPA and DHA supplements help promote heart and brain health as well as support eye and joint health. The growing elderly population who are more prone to chronic diseases and age-related health issues also contributes to the large size of the supplement sub-segment.
Global Analysis
The North American region dominates the global EPA and DHA market currently. This is attributed to rising awareness about nutritive benefits of EPA and DHA among consumers as well as growing incidences of cardiovascular diseases in the region. Rapid adoption of supplements as a preventive healthcare measure further drives the market in North America. The Asia Pacific region is projected to witness the fastest growth during the forecast period. Factors such as improving living standards, growing health expenditure and increasing consumer shift towards preventive healthcare will boost demand for EPA and DHA products in Asia Pacific.
Get More Insights On This Topic: https://www.ukwebwire.com/epa-and-dha-market-size-share-analysis-2023-2030/
Comments
0 comment